Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

Older adults' immune systems naturally weaken with age, making them more susceptible to COVID-19, influenza (flu) and RSV. Here's what you need to know about these respiratory viruses and why ...

A vaccination programme introduced to protect babies and older adults against a dangerous respiratory disease has cut ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

The respiratory syncytial virus (RSV) vaccine triggered strong immune responses among people aged 60 years and older during ...

RSV causes a common cold in most people affecting the airways and lungs. However for older adults can lead to severe lung infections like pneumonia. Steve Russell, NHS England director for ...

The new study, published in The Lancet Infectious Diseases, is the first to give evidence of the impact of the RSV vaccination program and underlines the importance of older adults coming forward ...

In adults aged 50 years and older, coadministration of respiratory syncytial virus vaccine mRNA-1345 plus seasonal influenza or COVID-19 vaccines was safe and noninferior to individual vaccine ...

The NHS has begun inviting older people in Oxfordshire to receive their respiratory syncytial virus (RSV) vaccine.

Respiratory syncytial virus (RSV) is known to cause considerable respiratory infection-related morbidity and mortality worldwide.1,2 Estimates published in 2022 from the UK highlight the ...